TMEM259

TMEM259 (Membralin) is a multi-pass endoplasmic reticulum membrane protein that functions in both ER-associated degradation (ERAD) and ER-phagy to maintain ER proteostasis and provide intrinsic antiviral defense. In its ERAD role, TMEM259 assembles with the ubiquitin ligase RNF185 and ubiquitin-like domain proteins TMUB1/TMUB2 into an ER membrane complex that cooperates with the cytosolic ubiquitin ligase UBE3C and the p97 ATPase to ubiquitinate and degrade misfolded ER membrane substrates such as CFTR and ABCB1 (PMID:32738194, PMID:38067172). Independently, TMEM259 acts as a non-canonical ER-phagy receptor: its luminal loop recruits the α-mannosidase MAN1B1, which serves as a glycan-density sensor to selectively recognize densely glycosylated viral class I fusion glycoproteins (SARS-CoV-2 spike, Ebola GP, influenza HA, HIV-1 Env), while its cytoplasmic tail contains a functional LC3-interacting region (LIR) that directs these substrates to lysosomes in a ubiquitin-independent manner via VCP/p97 (PMID:41324484, PMID:41799849). Loss of TMEM259 or MAN1B1 enhances pseudoviral infectivity, establishing this pathway as a mechanism of innate antiviral immunity that discriminates foreign from host glycoproteins (PMID:41324484).

1. 2002 Medium

   Before any function was known, cloning of TMEM259 (then C19orf6/Membralin) established it as an evolutionarily conserved multi-transmembrane protein with multiple splice variants, defining it as the sole member of a unique protein family and setting the stage for functional characterization.

   Evidence cDNA cloning, sequence analysis, and in situ hybridization in human, mouse, and rat tissues

   PMID:12638133

   Open questions at the time

   • No functional data; protein function entirely unknown
   • Subcellular localization not experimentally determined
   • No interacting partners identified
2. 2020 High

   A genome-wide CRISPR screen revealed that TMEM259 is a core component of an ER membrane ubiquitin ligase complex (with RNF185, TMUB1/2) that cooperates with UBE3C and p97 to degrade misfolded ER membrane substrates, establishing its role as an ERAD factor.

   Evidence CRISPR-Cas9 genome-wide screen, mass spectrometry interactome, reciprocal co-immunoprecipitation, and biochemical fractionation

   PMID:32738194

   Open questions at the time

   • Endogenous substrates of this ERAD branch not fully catalogued
   • Structural basis of TMEM259 interaction with RNF185 unknown
   • Whether TMEM259 has functions beyond ERAD not addressed
3. 2023 Medium

   Epistasis experiments placed the RNF185/Membralin complex upstream of or parallel to UBE3C in ERAD of clinically relevant substrates (ΔF508-CFTR, ABCB1), demonstrating that loss of both branches additively rescues functional CFTR at the plasma membrane.

   Evidence siRNA double knockdown with Ussing chamber/iodide efflux functional assays and flow cytometry for surface CFTR expression

   PMID:38067172

   Open questions at the time

   • Single-lab study; independent replication of epistasis in other cell types not yet available
   • Whether TMEM259 directly contacts these substrates or acts indirectly is unresolved
   • Relative contribution of TMEM259 versus RNF185 within the complex not dissected
4. 2025 High

   Discovery of a second, mechanistically distinct function: TMEM259 acts as a non-canonical ER-phagy receptor that uses its luminal loop to recruit MAN1B1 as a glycan-density sensor and its cytoplasmic LIR motif to deliver densely glycosylated viral fusion glycoproteins to lysosomes in a ubiquitin-independent manner, coupling ER proteostasis to innate antiviral defense.

   Evidence Co-immunoprecipitation, domain mutagenesis (LIR mutants, loop deletions), pseudoviral infectivity assays across multiple viral glycoproteins, lysosomal degradation and LC3 lipidation assays

   PMID:41324484 PMID:41799849

   Open questions at the time

   • Structural basis for MAN1B1-mediated glycan-density discrimination not resolved
   • In vivo relevance of TMEM259-dependent antiviral defense not demonstrated in animal models
   • Whether TMEM259 ER-phagy receptor function extends to non-viral heavily glycosylated substrates is untested

• Key open questions remain: the structural basis of TMEM259 complex assembly with RNF185 and MAN1B1, identification of the full spectrum of endogenous ERAD substrates, the in vivo significance of TMEM259-mediated antiviral ER-phagy, and whether the ERAD and ER-phagy functions are coordinated or mutually exclusive.
• No high-resolution structure of TMEM259 or its complexes
• No in vivo animal model phenotype reported for TMEM259 loss
• Coordination or switching between ERAD and ER-phagy functions of TMEM259 not characterized